Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 62, Issue 23, Pages -Publisher
WILEY
DOI: 10.1002/mnfr.201800392
Keywords
breast carcinogenesis; combination regimens; clinical applications; dietary phytochemicals
Categories
Funding
- Ministry of Science and Technology [105-2628-B-002-003-MY3, 105-2320-B-002-031-MY3]
Ask authors/readers for more resources
Starting from the 21st century, breast cancer can be classified as the most common invasive malignancy in women. Among the preventive or therapeutic strategies of breast cancer, combination therapy is the most promising approach. This mode of treatment of breast cancer concurrently maximizes efficacy, overcomes multidrug resistance, and minimizes harmful side effects caused by radiotherapy and chemotherapy alone. The risk of cancer can be reduced by supplementing diets with naturally occurring products known as phytochemicals. These phytochemicals have well-defined roles in the management of every stage of breast carcinogenesis. In this review, the collective data of dietary phytochemicals used to sensitize breast cancer cells to therapeutic approaches are reported and their specific molecular targets through synergistic, additive, and potentiation effects are highlighted. The concept of combining natural agents with medicines to augment therapeutic responses creates an optimal modality, which may facilitate clinical applications of combination regimens in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available